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Abstract
Background—Each year, 1.2 million metalworkers are exposed to metalworking fluids 
(MWFs), which can cause dermal and respiratory disease. The National Institute for Occupational 
Safety and Health (NIOSH) conducted a health hazard evaluation of MWF exposures at an aircraft 
engine manufacturing facility. The objectives were to determine employee exposures to endotoxin 
and MWFs in the air, characterize symptoms experienced by employees working with MWFs, 
compare them to symptoms of employees unexposed to MWFs, and make recommendations for 
reducing exposures based on results.
Methods—407 workers were categorized as MWF exposed or MWF unexposed and completed 
questionnaires. Estimated prevalence ratios (PR) of dermatitis, asthma, and work-related asthma 
(WRA) symptoms were calculated. Airborne concentrations of MWF and endotoxin were 
measured, and work practices observed.
Results—MWF exposed workers had a significantly higher prevalence of dermatitis on wrists/
forearms (PR 2.59; 95% CI 1.22, 5.46), asthma symptoms (PR 1.49; 95% CI 1.05, 2.13) and WRA 
symptoms (PR 2.10; 95% CI 1.22, 3.30) than unexposed workers. Airborne concentrations of 
MWF were below the NIOSH recommended exposure limit (REL) for MWF aerosols (thoracic 
particulate mass).
Conclusions—Despite MWF exposures below the NIOSH REL, exposed workers had a higher 
prevalence of asthma, WRA, and dermatitis symptoms than unexposed workers. 
Recommendations to reduce exposure included configuring mist collectors to automatically turn 
on when the machine is in use, and enforcing enclosure use.
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The National Institute for Occupational Safety and Health (NIOSH) received a request for a 
health hazard evaluation from the union at an aircraft engine manufacturing facility to 
evaluate the possible health hazards of exposure to metalworking fluids (MWFs). In January 
2010, a new formulation of a semisynthetic MWF was introduced because it had lower 
foaming properties than the previous formulation. The union was interested in determining if 
employees experienced symptoms with this new MWF and to contribute information that 
could be used in standard setting. The new MWF was used in the three central supply 
systems which fed approximately 275 machines in one large building.
Various types of aircraft engines were manufactured in the 70 year old, one storey facility of 
approximately one million square feet. Approximately 360 employees worked in 11 cells 
(areas) over three shifts. Most machines in these cells were served by three central MWF 
supply systems: north, south, and shaft. These systems used approximately 20,000 gallons of 
MWFs. Machining operations included grinding, cutting, milling, and drilling. The most 
common machines on the production floor were vertical turret lathes, which removed 
material from a rotating work piece with cutting tools, mills, and drills. Other machines on 
the production floor included turning centers and grinders. MWFs were used to cool the 
cutting tools and machined parts and to remove metal shavings. Several machines not 
connected to the central supply systems operated on their own stand alone MWF system. 
The MWFs in these stand-alone systems had different formulations from those in the central 
supply systems and were selected based on the requirements for specific tasks. Machines 
with various types of enclosures (fully enclosed, partially enclosed, no enclosure), with and 
without mist collectors, and different cutting methods (ceramic or carbide) were spread 
throughout the work area. Older machines had splash guards and were partially enclosed, 
whereas newer machines were typically fully enclosed and computer operated. Employees 
were usually assigned to one or two machines at a time during their shift. Employees 
reported that ceramic cutting was performed at faster speeds and could cause more misting 
of MWFs. Employees had opportunity for inhalational exposure to MWF when using 
machines with either no or a partial enclosure, or when opening an enclosed machine. There 
was opportunity for dermal exposure primarily when handling parts that had been machined 
or when maintaining or adjusting the machine.
Metalworking Fluids
MWFs, complex mixtures of synthetic, semisynthetic, and soluble oils are used to cool, 
lubricate, and remove metal chips from tools and parts during machining of metal stock. 
MWFs often contain other substances including biocides, corrosion inhibitors, metal fines, 
tramp oils, and biological contaminants [NIOSH, 1998; Burton et al., 2012]. Inhalation of 
MWF aerosols may irritate the throat, nose, and lungs and has been associated with chronic 
bronchitis, asthma, worsening of pre-existing respiratory problems, and hypersensitivity 
pneumonitis (HP) [Burton et al., 2012]. HP is a spectrum of granulomatous, interstitial lung 
diseases that occurs after repeated inhalation and sensitization to a wide variety of microbial 
agents (i.e., bacteria, fungi, amoebae), and low-molecular weight chemical antigens that can 
be contaminants of MWFs [CDC, 1996; Kreiss and Cox-Ganser, 1997; Zacharisen et al., 
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1998]. NIOSH recommends limiting exposures to MWF aerosols to 0.4 milligrams per cubic 
meter of air (mg/m3) for the thoracic particulate mass, as a TWA concentration for up to 10 
hours per day during a 40 hour work week [NIOSH, 1998]. Skin contact with MWFs may 
cause allergic contact dermatitis or irritant contact dermatitis depending on the chemical 
composition, additives and contaminants, type of metal being machined, and the exposed 
individual's tendency for developing allergies [WISHA, 2001].
MWFs are usually diluted with water and bacteria can grow if an inadequate amount of 
biocide is present. According to the Health and Safety Executive in the United Kingdom, 
well-maintained MWFs have bacterial concentrations below 103 colony-forming units per 
milliliter (CFU/mL) of fluid [HSE, 2006]. Concentrations between 103 to 106 CFU/mL 
indicate reasonable control, and concentrations greater than 106 CFU/mL indicate poor 
control [HSE, 2006]. The outer cell walls of Gram-negative bacteria may release 
lipopolysaccharide compounds called endotoxin when the bacteria die or multiply. 
Endotoxin is believed to cause adverse respiratory effects such as chronic bronchitis and 
asthma. In 2010, the Dutch Expert Committee on Occupational Safety recommended a 
health-based occupational exposure limit for airborne endotoxin of 90 EU/m3 [DECOS, 
2010]. Contaminated water in MWFs may contain fungi. Some fungi may infect susceptible 
hosts, such as immune compromised persons, and some fungi may cause HP. At this time, 
health data are insufficient to recommend a specific limit for fungal contamination in 
MWFs.
The objectives of this evaluation were to determine employee exposures to endotoxin and 
MWFs in the air, characterize symptoms experienced by employees working with MWFs 
and compare them to symptoms of employees unexposed to MWFs, and make 
recommendations for reducing exposures based on results.
MATERIALS AND METHODS
Questionnaire
We recruited employees in the aircraft manufacturing building and employees who worked 
in another building where MWF were not used. Comparison employees performed assembly 
work, packing, and shipping. Parts were washed prior to assembly to remove MWFs. 
Participants were defined as exposed to MWFs if they reported that they usually worked 
with MWF in their current job. Participating employees completed a questionnaire about 
demographics, work practices and location, personal protective equipment (PPE) use, hand 
hygiene, smoking status, and dermal and respiratory symptoms. This evaluation was 
conducted under a blanket institutional review board approval for the health hazard 
evaluation program because health hazard evaluations are generally not considered research 
but workplace evaluations. Written informed consent was not obtained because only a 
questionnaire was administered. Potential participants were told orally by NIOSH personnel 
that filling out the questionnaire was voluntary, and this was written on the cover of the 
questionnaire as well. The company is required to post the final report in a place accessible 
to all involved employees for 30 days.
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The dermal questions included questions modified from the Nordic Occupational Skin 
Questionnaire [Susitaival et al., 2003]. Three questions from the Nordic Occupational Skin 
Questionnaire pertaining to a previous history of asthma, eczema, or allergic rhinitis were 
used to determine if participants were atopic.
The respiratory questions included validated questions on asthma symptoms from the 
European Community Respiratory Health Survey [Grassi et al., 2003]. The questions were: 
(1) Have you been woken up with a feeling of tightness in your chest at any time in the last 
12 months?; (2) Have you had an attack of asthma in the last 12 months?; (3) Are you 
currently taking any medicine (including inhalers or pumps, aerosols, or tablets) for 
asthma?; and (4) Have you had wheezing or whistling in your chest at any time in the last 12 
months? If a participant answered yes to (4) they were asked a) Have you been at all 
breathless when the wheezing or whistling noise was present? and b) Have you had this 
wheezing or whistling when you did not have a cold? If a participant answered yes to any of 
these questions, they were classified as having asthma symptoms. Being classified as having 
asthma symptoms by the survey has a sensitivity of 75% and a specificity of 80% for asthma 
based upon a clinical examination with IgE testing against common allergens, spirometry, 
and methacholine challenge testing [Grassi et al. 2003]. We modified these questions by 
adding the following, “or since beginning your current position if in that position less than 
12 months”, since some participants had not been in their current position for 12 months. 
We asked additional questions regarding work-relatedness. These questions included 
changes in symptoms or medication used on days off work or on vacation. If the participant 
responded that symptoms improved on days off work or on vacation, or that medication use 
was less frequent on days off or on vacation, then their symptoms were classified as work-
related.
A question regarding problems with sneezing, runny nose, or blocked nose in the last 12 
months probed work-related rhinoconjunctivitis and was adapted from the International 
Study of Asthma and Allergies in Childhood [Asher et al., 1995]. These questions included 
changes in symptoms on days off work or on vacation. If the participant responded that 
symptoms improved on days off work or on vacation, then their symptoms were classified as 
work-related.
A question regarding more than one episode of illness in the last 12 months with at least two 
of the following symptoms: cough, wheeze, shortness of breath, or chest tightness was based 
on diagnostic criteria for hypersensitivity pneumonitis (HP) identified in two prior studies 
[Fox et al. 1999; Lacasse et al. 2003]. If participants answered yes to this question, they 
were asked if they had fever or weight loss with these episodes. If they answered yes, they 
were classified as having symptoms of HP. Participants were also asked if they had 
pneumonia or chest flu in the last 12 months, and if yes, how many times. This was asked 
because HP is often misdiagnosed as pneumonia or chest flu. We compared the number of 
times these illnesses were reported between exposed and unexposed participants.
Metalworking Fluid Sampling
Full-shift personal breathing zone (PBZ) air samples for MWF aerosols (thoracic particulate 
mass and extracted MWF) were collected over 2 days of sampling. Air samples for MWFs 
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were collected using 37mm closed-faced three-piece cassettes containing a tared 2 μm pore 
size polytetrafluoroethylene filter and the supporting pad. The sampling train consisted of 
the 37 mm cassette, a BGI thoracic cyclone (BGI Incorporated, Waltham, Massachusetts), 
and Tygon® tubing connecting the sampling assembly to SKC Air Check® 2000 air 
sampling pumps (SKC Inc., Eighty Four, Pennsylvania). A sampling rate of 1.6 liters per 
minute (lpm) was used to collect the thoracic fraction of the aerosol. Each pump was 
calibrated before and after use. The sampling media was attached to the employee's lapel 
within the breathing zone (breathing zone is defined as an area in front of the shoulders with 
a radius of 6 to 9 inches). The samples were analyzed by gravimetric analysis for the 
thoracic fraction of MWF particulates per NIOSH Method 5524 [NIOSH, 2012]. After the 
filter was gravimetrically weighed, a ternary solvent blend was used to extract the MWF 
fraction from each sample.
We collected bulk samples of MWFs from each of the central supply systems, unused 
MWFs, and the water that was mixed with the concentrated MWFs. Eight bulk MWF 
samples were collected and analyzed by culture for bacteria, mycobacteria, and fungi by a 
contract laboratory.
Endotoxin Sampling
We collected area endotoxin air samples at the employees’ work stations where the 
employees spent the majority of the work day instead of PBZ samples because the 
employees were already wearing two PBZ pumps. Background concentrations of endotoxin 
were collected in a meeting room of a separate building. Air samples were collected using 
an endotoxin free 3 -piece 37-mm closed-face cassette, preloaded with 0.45 μm pore-size 
filters. Samples were collected with SKC AirCheck2000 personal air sampling pumps 
calibrated at 2 lpm. Each pump was calibrated before and after use. Endotoxin analysis was 
performed by a contract laboratory. Samples were analyzed for endotoxin content with the 
kinetic-chromogenic procedure using the limulus amebocyte lysate assay [Cambrex, 2005]. 
For these analyses, one endotoxin unit (EU) was equivalent to 0.053 nanograms of 
endotoxin. The limit of detection was 0.025 EU per sample.
Microbial Sampling
MWF samples were collected by filling 1 liter sterile bottles, leaving at least 2 inches of 
headspace. Samples were kept at ambient room temperature and shipped within 2 days to the 
laboratory for analysis. Each sample was concentrated by a 30-minute centrifuge and excess 
fluid was poured off. The concentrate was vortexed for 1 minute and then plated to the 
appropriate media. For aerobic bacteria, the media was tryptic soy agar with polysorbate 80 
and lecithin and buffered charcoal yeast extract agar. Plates were incubated at 23°C ± 2°C 
for 5 to 7 days and read daily. The media for fungi was yeast malt extract, inhibitory mold 
agar with gentamicin and chloramphenicol, and buffered charcoal yeast extract agar. These 
plates were incubated at 23°C ± 2°C for 10 days. Plates were read on day 3 to see if they 
were overgrown, and on days 5 or 7 and day 10. The media for mycobacteria was buffered 
charcoal yeast extract agar, Middlebrook 7H10, and Mitchison 7H11S. Plates and broth 
were incubated at 32°C ± 2°C in 7–10% CO2 for 4 weeks. Cultures were read at 3 to 5 days 
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and 7 days. If specimens were overgrown, additional dilutions were made. A Ziehl–Neelsen 
stain of broths was performed at 2–3 weeks and 4 weeks [MSI, 2011].
Statistical Analysis
All data were analyzed using SAS 9.2 (SAS Institute Inc., Cary, North Carolina). Symptoms 
were analyzed by age, sex, smoking status, hours worked per week, work area, and job title. 
A log binomial model directly modeled the prevalence ratio [Skov et al., 1998], and was 
used to estimate prevalence ratio (PR) with 95% confidence intervals (95% CI) for dermal 
and respiratory outcomes. Fitted models for dermal outcomes were adjusted for atopy and 
fitted models for respiratory outcomes were adjusted for smoking status. Chi square or 
Fisher's exact tests were calculated to determine if there was an association between 
exposure to MWFs and dermal and respiratory symptoms. The Fisher's exact test was used 
for sparse data. A P-value equal to or less than 0.05 was considered significant.
RESULTS
Questionnaire
Four hundred and seven employees completed the questionnaire. The participation rate was 
82% (183/223) among the exposed group and 87% (224/257) among the unexposed group. 
Ninety-four percent of participants were aged 45 years or older (Table I). A higher 
proportion (64%) of exposed participants worked more than 40 hours per week than did 
unexposed participants (45%). The proportion of participants who currently smoked was 
similar between groups, although more exposed participants (43%) were former smokers. 
The proportion of participants who were atopic was similar between exposed (60%) and 
unexposed (53%).
The prevalence of dermatitis in the last 12 months was statistically significantly greater in 
the exposed group than in the unexposed group after controlling for atopy (PR 1.86; 95% CI 
1.20, 2.90) (Table II). The most common location of dermatitis in both groups was the hands 
or fingers (16% exposed and 9% unexposed). Almost half of those reporting dermatitis in 
the past 12 months in both the exposed and unexposed groups reported having dermatitis 
currently. A significantly higher proportion of exposed participants reported that their 
dermatitis symptoms were reduced with more than 5 days away from work (PR 2.50; 95% 
CI 1.39, 4.49) (Table II).
Exposed and unexposed participants reported similar frequency of glove use, but exposed 
participants were significantly more likely to wear synthetic rubber (51% vs. 41%, P 
=0.049) and leather gloves (49% vs. 27%, P <0.01). Unexposed participants wore gloves to 
protect against cuts and abrasions during assembly work. Hand hygiene practices (use of 
barrier cream, hand washing, use of hand-wipes or solvents to clean hands) did not differ 
significantly between exposed and unexposed participants. For the most part, hand hygiene 
practices, glove use, and glove type did not differ significantly between those who reported 
dermatitis on their hands or fingers, or wrists or forearms in the last 12 months and those 
who did not (Table III). However, participants with dermatitis on their hands or fingers, or 
wrists or forearms in the last 12 months were significantly more likely to apply barrier 
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cream at work (PR 4.64; 95% CI 2.29, 9.37) (Table III). Only 22% (9/41) of exposed 
participants with dermatitis in the last 12 months reported seeing a doctor for their 
dermatitis. Of these, none had patch testing.
The proportion of participants who reported ever having asthma was similar between the 
exposed (11%) and unexposed groups (9%). One third of those who reported ever having 
asthma reported that their asthma began during their current job (33% exposed and 32% 
unexposed). The asthma symptoms listed by exposure group in Table IV were taken from 
the European Community Respiratory Health Survey. A positive response to any one 
symptom indicates potential asthma. The prevalence of work-related wheezing or whistling 
in the chest was significantly higher for the exposed than the unexposed participants after 
controlling for cigarette smoking status (PR 2.84; 95% CI 1.56, 5.18)) (Table IV). The 
prevalence of participants who reported at least one asthma symptom (PR 1.49; 95% CI 
1.05, 2.13) was significantly higher for participants exposed to MWFs than unexposed 
participants after controlling for cigarette smoking status, as was the prevalence of 
participants who reported at least one work-related asthma symptom (PR 1.92; 95% CI 1.19, 
3.09) (Table IV). Because the REL is for a 40-hour work week, we compared the prevalence 
of asthma symptoms and work-related asthma symptoms between exposed participants who 
worked 40 hours per week or less and those who worked more than 40 hours per week. 
There was no significant difference between these groups.
The proportion of sneezing, runny nose, or blocked nose was similar between exposed 
(52%) and unexposed participants (41%); however, the prevalence of work-related nasal 
symptoms was significantly higher among the exposed (PR 1.36; CI: 1.003-1.86).
The prevalence of reported symptoms of HP by either of our definitions did not differ 
between exposed and unexposed participants. Six percent of exposed and unexposed 
participants reported one or more episodes of fever and weight loss in the last 12 months 
plus at least two of cough, wheeze, shortness of breath, or chest tightness. Less than 1% of 
participants in each group reported having pneumonia or chest flu more than twice in the last 
12 months.
Metalworking Fluid Sampling
We collected 48 PBZ air samples and nine area air samples for MWFs. Each sample was 
analyzed for thoracic particulates and the extractable fraction of MWFs. Thoracic 
particulates include all dust and other aerosols in the air (such as bioaerosols) in addition to 
the MWFs. The extractable fraction represents the portion of the sample that was MWFs.
Overall, concentrations of thoracic particulates and extracted MWFs were very low and did 
not exceed the NIOSH REL for thoracic particulates of 0.4 mg/m3. Eighteen of 43 PBZ air 
samples analyzed for thoracic particulates were quantifiable (mean of 0.16 mg/m3 ; range: 
0.11-0.29 mg/m3) and 25 had concentrations between the minimum detectable concentration 
of 0.03 mg/m3 and minimum quantifiable concentration of 0.12 mg/m3. None of the air 
samples had quantifiable concentrations of extracted MWFs and only 4 of 43 PBZ air 
samples had extracted MWF concentrations between the minimum detectable concentration 
of 0.14 mg/m3 and the minimum quantifiable concentration of 0.5 mg/m3. Three air samples 
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were taken on employees who did not work directly with MWF from the central systems 
(i.e., they worked on a machine on a stand-alone system or in hot oil flush), but their work 
stations were surrounded by machines that were on the central systems. These 
concentrations were comparable to those found in the other air samples.
Endotoxin Sampling
We took 20 area air samples for endotoxin throughout the plant; two samples were taken in 
a meeting room in a completely separate area. Endotoxin concentrations in the areas with 
MWF use ranged from 0.42 EU/m3 to 2.7 EU/m3 with a mean of 1.2 EU/m3. The meeting 
room sample concentrations were 0.23 EU/m3 and 0.24 EU/m3.
Microbial Sampling
Two bulk samples from each of the central systems were collected for microbial analysis. 
An unused sample of MWFs mixed from concentrated MWFs and deionized water to the 
manufacturer's recommended concentration, and a sample of the deionized water used to 
dilute the MWFs were also collected and analyzed. Bacteria counts ranged from 3 to 401 
CFU/mL. Two types of bacteria were found in the deionized water. All bacterial 
concentrations were low, below 103 CFU/mL of fluid. The deionized water contained four 
types of fungi. Although the shaft central system had no bacteria isolated, Penicillium spp. 
(a fungus) was isolated. The north and shaft central systems had mycobacteria; these were 
identified as a Ziehl-Neelsen stain species, but the laboratory was unable to identify the 
exact species. Bulk samples collected by the company at the same time as the NIOSH 
samples had similar results; however, the company's results showed higher bacteria counts 
(up to 4,000 CFU/mL). Fungi were not detected except in the deionized water sample (30 
CFU/mL). Both sets of results showed that the deionized water used to dilute the MWF 
concentrate for the central systems had low levels of bacteria.
Other Observations
We observed that some machines had mist collector systems, enclosures, and splash guards 
which operators did not always use when the machines were in use. In specific instances, 
enclosures and splash guards were not closed completely when the machines were in use. In 
other cases, mist collectors were not turned on. Most employees wore short sleeve shirts 
when working in areas where MWFs were present.
DISCUSSION
Despite the low airborne concentrations of MWF, exposed participants were significantly 
more likely to report asthma symptoms as well as work-related asthma symptoms than 
unexposed participants. Case reports of occupational asthma have demonstrated that the 
NIOSH REL for MWFs does not consistently protect against allergic respiratory 
sensitization [Kreiss and Cox-Ganser, 1997; Mapp et al., 2005]. NIOSH recognized and 
stated that the REL might not be protective of all employees when the REL was introduced 
[NIOSH, 1998]. Recent Finnish studies have similar findings to this evaluation. A study that 
compared machine workers using mainly water-miscible MWFs to office workers from 64 
Finnish companies found very low respirable aerosol concentrations (geometric mean of 
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0.12 mg/m3) in the breathing zones of the machine workers, yet still found a significant 
excess of upper and lower respiratory symptoms and current asthma among the machine 
workers [Jaakkola et al. 2009]. There was no significant difference between exposed and 
unexposed participants in our evaluation when were asked if they ever had asthma. This 
discrepancy between reporting symptoms and history of a diagnosis of asthma in this 
workforce may indicate an underdiagnosis of asthma. Lack of recognition and identification 
of work relatedness are likely for diseases with symptoms common to non-occupational 
disorders or those with multiple causal factors [Milton et al., 1998].
In our evaluation, exposed participants were significantly more likely to report dermatitis in 
the last 12 months. Dermatitis on the wrist and forearm was significantly more prevalent 
among exposed participants. We noted many employees wearing short sleeves, which may 
allow wrist and forearm contact with MWFs while the hands are protected by gloves. We 
recommended use of protective sleeves to prevent forearm contact with MWFs. Barrier 
creams were used by some employees, presumably to prevent dermatitis. However, the 
evidence of the protective nature of these topical products during actual working conditions 
is limited [Schwantiz et al., 2003; Loffler et al., 2006; Weisshaar et al., 2006]. In our 
evaluation, those with dermatitis were significantly more likely to report using barrier 
creams than those without dermatitis. It is unclear if they are using the cream because they 
have dermatitis or if the dermatitis is caused or exacerbated by the barrier cream.
This evaluation has several limitations. The cross-sectional design of the evaluation means 
that exposures and symptoms were captured at the same time. Thus the study does not 
provide strong evidence of causality. Inquiring about symptoms over a year's period may 
introduce recall bias. Industrial hygiene sampling can only document exposures on the days 
of sampling in the locations sampled. We did not perform clinical examinations to diagnose 
dermatitis and asthma. However, the European Community Respiratory Health Survey 
questions have a sensitivity of 75% and a specificity of 80% for asthma symptoms based 
upon a clinical examination with IgE testing against common allergens, spirometry, and 
methacholine challenge testing, and the dermal questions include standardized questions 
modified from the Nordic Occupational Skin Questionnaire which is widely used in studies 
of dermatitis [Grassi et al., 2003; Susitaival et al., 2003]. The European Community 
Respiratory Health Survey questionnaire was validated among 20 to 44-year-olds, however, 
while an older group of 45 to 70 year old subjects were studied in the Netherlands [Kerkhof 
et al., 1994 in Abramson et al., 2002]. Our population was mostly over age 45 years. 
However, our participants were healthy enough to be fully employed, and the European 
Community Respiratory Health Survey has been previously used in a published study of 
asthma in older adults [Abramson et al., 2002]. Another limitation of this evaluation was a 
lack of similar data for prior MWF exposure. It would be beneficial for the company to have 
been able to compare employee symptoms before and after the introduction of the new 
MWF formulation.
In conclusion, participants exposed to MWFs reported significantly higher prevalence rates 
of work-related dermatitis and work-related asthma symptoms in the previous 12 months 
than participants not exposed to MWFs despite airborne exposure to MWFs being below the 
REL. Following a preventive maintenance program for the mist collectors and appropriate 
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use of engineering controls (i.e., machine enclosures, splash guards, mist collectors) could 
lower airborne levels of MWFs. We recommended configuring mist collectors to 
automatically turn on when the machine is in use, and enforce enclosure use. Instituting a 
medical surveillance program would enable earlier identification of work-related respiratory 
and skin symptoms.
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Table I
Characteristics of participants by exposure group (n=407)
Characteristics Total Number (%) Exposed Number (%) n=183 Unexposed Number (%) n=224
Age in years
    18-24 2 (<1) 1 (1 ) 1 (<1)
    25-34 11 (3) - 11 (5)
    35-44 10 (2) 5 (3) 5 (2)
    45-54 163 (40) 88 (48) 75 (33)
    55-64 212 (52) 83 (45) 129 (58)
    65+ 8 (2) 5 (3) 3 (1)
    Unknown 1 (<1) 1 (1) -
Sex
    Male 340 (84) 174 (95) 166 (74)
    Female 67 (16) 9 (5) 58 (26)
Smoking Status
    Never 190 (47) 75 (41) 115 (51)
    Former 152 (37) 79 (43) 73 (33)
    Current 59 (15) 26 (14) 33 (15)
    Unknown 6 (1) 3 (2) 3 (1)
Hours Worked/Week
Up to 40 192 (47) 69 (36) 123 (55)
41+ 214 (53) 113 (64) 101 (45)
Atopy 228 (56) 110 (60) 118 (53)
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Prevalence Ratio (95% 
Confidence Interval)
a
Dermatitis in the last 12 months 41 (22) 25 (11) 1.86 (1.20-2.90)
    Location of dermatitis
b
        Hands or fingers 30 (16) 21 (9) 1.61 (0.97-2.68)
        Wrists or forearm 20 (11) 9 (4) 2.45 (1.16-5.17)
        Face or neck 12 (7) 8 (4) 1.65 (0.70- 3.90)
    Dermatitis currently 20 (11) 12 (5) 1.89 (0.96-3.72)
    Dermatitis better when away from work more than 5 days 31 (17) 14 (6) 2.50 (1.39-4.49)
    Changed job due to dermatitis 2 (1) 1 (<1) 2.15 (0.20-23.33)
    Changed glove type or began wearing gloves because of 
dermatitis




Some participants reported more than one location of dermatitis
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Table III
Hand hygiene practices and glove use by dermatitis on the hands or fingers, or wrists or forearms, in the last 
12 months for exposed and unexposed participants combined
Dermatitis in the Last 
12 Months Number (%) 
n=58
No Dermatitis in the Last 
12 Months Number (%) 
n=348-349
a
Prevalence Ratio (95% 
Confidence Interval)
b
Applies barrier cream at work 12 (21) 20 (6) 4.64 (2.29-9.37)
Wash hands at least once per shift 58 (100) 345 (99) -
Use hand-wipes to clean hands at least once per shift 33 (57) 186 (53) 1.13 (0.87-1.46)
Applies moisturizing lotion to hands or arms at work 31 (53) 190 (55) 0.98 (0.75-1.28)
Uses solvents to clean hands at work 8 (14) 24 (7) 2.23 (1.00-4.96)
Use gloves all of the time 19 (33) 90 (26) 1.33 (0.87-2.04)
Use gloves at least some of the time 56 (97) 320 (92) 1.07 (0.98-1.17)
a
Denominators vary due to missing information
b
Adjusted for atopy
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Table IV
Prevalence of asthma symptoms by exposure category
a




Prevalence Ratio (95% 
Confidence Interval)
Wheezing or whistling in chest
b 46 (25) 35 (16) 1.54 (1.03-2.29)
    Breathless when wheezing or whistling 18 (10) 19 (9) 1.13 (0.61-2.10)
    Wheezing or whistling without a cold 37 (20) 26 (12) 1.66 (1.04-2.66)
    Wheezing or whistling better on days off/vacation 32 (17) 14 (6) 2.84 (1.56-5.18)
Attack of asthma
b 6 (3) 6 (3) 1.22 (0.40-3.76)
    Attacks of asthma less often on days off/vacation 5 (3) 5 (2) 1.21 (0.35-4.13)
Woken up with feeling of tightness in chest
b 26 (14) 13 (6) 2.47 (1.30-4.69)
    Episodes of chest tightness less often on days off/vacation 18 (10) 10 (4) 2.22 (1.05-4.72)
Currently taking any medicine for asthma
b 10 (5) 12 (5) 1.05 (0.46-2.39)
    Take medicine less often on days off/vacation 5 (3) 3 (1) 2.28 (0.55-9.42)
Asthma symptoms
c 54 (30) 43 (19) 1.49 (1.05-2.13)
    Work-related asthma symptoms 37 (20) 24 (11) 1.92 (1.19-3.09)
a
Controlled for smoking status
b
Derived from European Community Respiratory Health Survey; positive answer to any one indicates potential asthma
c
Asthma symptoms based upon a positive answer to one or more of four European Community Respiratory Health Survey questions
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